Epigallocatechin gallate (EGCG) binds to low-density lipoproteins (LDL) and protects them from oxidation and glycation under high-glucose conditions mimicking diabetes

被引：21

作者：

Wu, Chi-Hao ^{[1
]}

Yeh, Chi-Tai ^{[2
]}

Yen, Gow-Chin ^{[1
]}

机构：

[1] Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, Taichung 40227, Taiwan

[2] Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli Cty 350, Taiwan

来源：

FOOD CHEMISTRY | 2010年 / 121卷 / 03期

关键词：

Binding; EGCG; Glucose; Glycation; LDL; Oxidation; NATURALLY-OCCURRING FLAVONOIDS; GREEN TEA; PHENOLIC-COMPOUNDS; POTENTIAL ROLE; HUMAN PLASMA; (-)-EPIGALLOCATECHIN; CATECHINS; SUPPLEMENTATION; GLYCOXIDATION; VOLUNTEERS;

D O I：

10.1016/j.foodchem.2010.02.008

中图分类号：

O69 [应用化学];

学科分类号：

081704 ;

摘要：

The aim of this study was to determine whether low-density lipoprotein (LDL)-bound epigallocatechin gallate (EGCG) attenuates LDL oxidation and glycation under high-glucose (HG) conditions mimicking diabetes. Pooled plasma was preincubated with EGCG for three hours, followed by sequential ultracentrifugation and extensive dialysis to isolate LDL. The kinetics of a-tocopherol and EGCG consumption in LDL were measured by a solid-phase extraction system with HPLC-diode array detection (HPLC-DAD) upon oxidation. EGCG enrichment effectively increased the resistance of LDL to oxidation caused by HG/Cu2+. A dose-dependent inhibition of HG-mediated long-term glycation of LDL was also observed by LDL-bound EGCG. Data from HPLC-DAD demonstrated that EGCG was able to bind lipoproteins and to facilitate the antioxidant and antiglycation properties of LDL. This study suggests that loading plasma with EGCG is an efficient way to increase the content of this phytochemical in LDL, which may imply favourable in vivo activity of EGCG in diabetes. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：639 / 644

页数：6

共 32 条

[1]

Basu A, 2007, NUTR REV, V65, P361, DOI [10.1301/nr.2007.aug.361-375, 10.1111/j.1753-4887.2007.tb00314.x]

[2] The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation [J].

Belinky, PA ;

Aviram, M ;

Fuhrman, B ;

Rosenblat, M ;

Vaya, J .

ATHEROSCLEROSIS, 1998, 137 (01) :49-61

[3] Glucose and reactive oxygen species [J].

Bonnefont-Rousselot, D .

CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2002, 5 (05) :561-568

[4] Supplementation with wine phenolic compounds increases the antioxidant capacity of plasma and vitamin E of low-density lipoprotein without changing the lipoprotein Cu2+-oxidizability: Possible explanation by phenolic location [J].

Carbonneau, MA ;

Leger, CL ;

Monnier, L ;

Bonnet, C ;

Michel, F ;

Fouret, G ;

Dedieu, F ;

Descomps, B .

EUROPEAN JOURNAL OF CLINICAL NUTRITION, 1997, 51 (10) :682-690

[5] CONTINUOUS MONITORING OF INVITRO OXIDATION OF HUMAN LOW-DENSITY LIPOPROTEIN [J].

ESTERBAUER, H ;

STRIEGL, G ;

PUHL, H ;

ROTHENEDER, M .

FREE RADICAL RESEARCH COMMUNICATIONS, 1989, 6 (01) :67-75

[6] GREEN TEA COMPOSITION, CONSUMPTION, AND POLYPHENOL CHEMISTRY [J].

GRAHAM, HN .

PREVENTIVE MEDICINE, 1992, 21 (03) :334-350

[7] Antihyperglycentic effect of oolong tea in type 2 diabetes [J].

Hosoda, K ;

Wang, MF ;

Liao, ML ;

Chuang, CK ;

Iha, M ;

Clevidence, B ;

Yamamoto, S .

DIABETES CARE, 2003, 26 (06) :1714-1718

[8] The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults [J].

Iso, H ;

Date, C ;

Wakai, K ;

Fukui, M ;

Tamakoshi, A .

ANNALS OF INTERNAL MEDICINE, 2006, 144 (08) :554-562

[9] 'Lipoproteins, glycoxidation and diabetic angiopathy' [J].

Jenkins, AJ ;

Best, JD ;

Klein, RL ;

Lyons, TJ .

DIABETES-METABOLISM RESEARCH AND REVIEWS, 2004, 20 (05) :349-368

[10]

Lamuela-Raventós RM, 1999, CLIN CHEM, V45, P1870

← 1 2 3 4 →